药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Oxamniquine
Pinaverium
The risk or severity of QTc prolongation can be increased when Pinaverium is combined with Nilotinib.
Oxamniquine
Trimebutine
The risk or severity of QTc prolongation can be increased when Trimebutine is combined with Nilotinib.
Oxamniquine
Olodaterol
The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Nilotinib.
Oxamniquine
Flumequine
The risk or severity of QTc prolongation can be increased when Flumequine is combined with Nilotinib.
Oxamniquine
Chlorcyclizine
The risk or severity of QTc prolongation can be increased when Chlorcyclizine is combined with Nilotinib.
Oxamniquine
Geranylgeranyl diphosphate
The risk or severity of QTc prolongation can be increased when Geranylgeranyl diphosphate is combined with Nilotinib.
Oxamniquine
Farnesyl diphosphate
The risk or severity of QTc prolongation can be increased when Farnesyl diphosphate is combined with Nilotinib.
Oxamniquine
Triptorelin
The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Nilotinib.
Oxamniquine
Histrelin
The risk or severity of QTc prolongation can be increased when Histrelin is combined with Nilotinib.
Oxamniquine
Buserelin
The risk or severity of QTc prolongation can be increased when Buserelin is combined with Nilotinib.
Oxamniquine
Degarelix
The risk or severity of QTc prolongation can be increased when Degarelix is combined with Nilotinib.
Oxamniquine
Mepyramine
The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Nilotinib.
Oxamniquine
Cariporide
The risk or severity of QTc prolongation can be increased when Cariporide is combined with Nilotinib.
Oxamniquine
Amisulpride
The risk or severity of QTc prolongation can be increased when Amisulpride is combined with Nilotinib.
Oxamniquine
Levocetirizine
The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Nilotinib.
Oxamniquine
Tandutinib
The risk or severity of QTc prolongation can be increased when Tandutinib is combined with Nilotinib.
Oxamniquine
Methsuximide
The risk or severity of QTc prolongation can be increased when Methsuximide is combined with Nilotinib.
Oxamniquine
Indacaterol
The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Nilotinib.
Oxamniquine
Ezogabine
The risk or severity of QTc prolongation can be increased when Ezogabine is combined with Nilotinib.
Oxamniquine
Farnesyl thiopyrophosphate
The risk or severity of QTc prolongation can be increased when Farnesyl thiopyrophosphate is combined with Nilotinib.